Eric Schoen - 17 Apr 2024 Form 4 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role
Chief Financial Officer
Signature
/s/ Eric J. Schoen
Issuer symbol
SAVA
Transactions as of
17 Apr 2024
Transactions value $
$33,000
Form type
4
Filing time
17 Apr 2024, 16:21:18 UTC
Previous filing
04 Oct 2023
Next filing
22 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAVA Common Stock Options Exercise $33K +1.5K +7.58% $22.00 21.3K 17 Apr 2024 Direct F1
holding SAVA Common Stock 2K 17 Apr 2024 By limited liability corporation

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAVA Common Stock Warrant Award $0 +7.92K $0.00 7.92K 03 Jan 2024 Common Stock 11.9K $33.00 Direct F2
transaction SAVA Common Stock Warrant Award $0 +800 $0.00 800 03 Jan 2024 Common Stock 1.2K $33.00 By limited liability corporation F2
transaction SAVA Common Stock Warrant Options Exercise $0 -1K -12.63% $0.00 6.92K 17 Apr 2024 Common Stock 1.5K $33.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.
F2 Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.